Title: Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
Authors: Hu, Jialiang *
Van den Steen, Philippe *
Sang, Qing-Xiang A
Opdenakker, Ghislain # ×
Issue Date: Jun-2007
Publisher: Nature Pub. Group
Series Title: Nature Reviews. Drug Discovery vol:6 issue:6 pages:480-498
Abstract: Matrix metalloproteinases (MMPs) have outgrown the field of extracellular-matrix biology and have progressed towards being important regulatory molecules in cancer and inflammation. This rise in status was accompanied by the development of various classes of inhibitors. Although clinical trials with synthetic inhibitors for the treatment of cancer were disappointing, recent data indicate that the use of selective inhibitors might lead to new therapies for acute and chronic inflammatory and vascular diseases. In this Review, we compare the major classes of MMP inhibitors and advocate that future drug discovery should be based on crucial insights into the differential roles of specific MMPs in pathophysiology obtained with animal models, including knockout studies.
ISSN: 1474-1776
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Immunobiology (Rega Institute)
* (joint) first author
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science